locametz
novartis europharm limited - gozetotide - obrazowanie radionuklidami - diagnostyczne radiofarmaceutyki - ten produkt leczniczy jest przeznaczony wyłącznie do celów diagnostycznych. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.
prograf 5 mg/ml koncentrat do sporządzania roztworu do infuzji
astellas pharma sp. z o.o. - tacrolimus - koncentrat do sporządzania roztworu do infuzji - 5 mg/ml
prograf 5 mg kapsułki twarde
astellas pharma sp. z o.o. - tacrolimus - kapsułki twarde - 5 mg
prograf 0,5 mg kapsułki
astellas pharma sp. z o.o. - tacrolimus - kapsułki - 0,5 mg
prograf 1 mg kapsułki twarde
astellas pharma sp. z o.o. - tacrolimus - kapsułki twarde - 1 mg
finasteride symphar 5 mg tabletki powlekane
symphar sp. z o.o. - finasteridum - tabletki powlekane - 5 mg
medithyrox 13 mcg tabletki
uni-pharma kleon tsetis pharmaceutical laboratoires s.a. - levothyroxine sodium - tabletki - 13 mcg
medithyrox 62 mcg tabletki
uni-pharma kleon tsetis pharmaceutical laboratoires s.a. - levothyroxine sodium - tabletki - 62 mcg
medithyrox 88 mcg tabletki
uni-pharma kleon tsetis pharmaceutical laboratoires s.a. - levothyroxinum natricum - tabletki - 88 mcg
medithyrox 112 mcg tabletki
uni-pharma kleon tsetis pharmaceutical laboratoires s.a. - levothyroxinum natricum - tabletki - 112 mcg